PMV Pharmaceuticals, Inc. (PMVP)
1.70
+0.33
(+24.09%)
USD |
NASDAQ |
Feb 27, 16:00
1.66
-0.04
(-2.35%)
After-Hours: 20:00
PMV Pharmaceuticals Shareholders Equity (Quarterly) : 121.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 203.28M |
| Aclaris Therapeutics, Inc. | 103.08M |
| Atea Pharmaceuticals, Inc. | 315.78M |
| Instil Bio, Inc. | 120.42M |
| Alumis, Inc. | 384.77M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.84M |
| Total Liabilities (Quarterly) | 12.84M |
| Debt to Equity Ratio | 0.0077 |
| Current Ratio | 10.76 |
| Net Debt Paydown Yield | 3.25% |